---
title: Clinical validation of a prognostic preclinical magnetic resonance imaging
  biomarker for radiotherapy outcome in head-and-neck cancer
date: '2024-12-29'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39733969/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20241230170904&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSIONS: A preclinical prognostic model defined by an ADC-based
  HRS was successfully retrained and validated in HNC patients treated with radiochemotherapy.
  After thorough external validation, such functional HRS based on a band of ADC values
  may in the future allow interventional response-adaptive MRI-guided radiotherapy
  in online and offline ...'
disable_comments: true
---
CONCLUSIONS: A preclinical prognostic model defined by an ADC-based HRS was successfully retrained and validated in HNC patients treated with radiochemotherapy. After thorough external validation, such functional HRS based on a band of ADC values may in the future allow interventional response-adaptive MRI-guided radiotherapy in online and offline ...